Group One Trading’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-1,500
| Closed | -$4K | – | 5827 |
|
|
2018
Q1 | $4K | Buy |
+1,500
| New | +$3.79K | ﹤0.01% | 4576 |
|
|
2017
Q3 | – | Sell |
-7,600
| Closed | -$31K | – | 5542 |
|
|
2017
Q2 | $31K | Buy |
7,600
+3,600
| +90% | +$15.7K | ﹤0.01% | 3770 |
|
|
2017
Q1 | $15K | Sell |
4,000
-38,100
| -90% | -$120K | ﹤0.01% | 4003 |
|
|
2016
Q4 | $82K | Buy |
42,100
+41,800
| +13,933% | +$151K | ﹤0.01% | 2965 |
|
|
2016
Q3 | $2K | Buy |
+300
| New | +$1.85K | ﹤0.01% | 4407 |
|
|
2016
Q1 | – | Sell |
-500
| Closed | -$15K | – | 5355 |
|
|
2015
Q4 | $15K | Sell |
500
-9,500
| -95% | -$287K | ﹤0.01% | 4051 |
|
|
2015
Q3 | $316K | Buy |
10,000
+3,650
| +57% | +$175K | ﹤0.01% | 2164 |
|
|
2015
Q2 | $376K | Buy |
6,350
+1,190
| +23% | +$83.9K | 0.01% | 2025 |
|
|
2015
Q1 | $552K | Sell |
5,160
-1,330
| -20% | -$127K | 0.01% | 1517 |
|
|
2014
Q4 | $609K | Buy |
6,490
+200
| +3% | +$19.1K | 0.01% | 1408 |
|
|
2014
Q3 | $483K | Sell |
6,290
-14,150
| -69% | -$1.11M | 0.01% | 1656 |
|
|
2014
Q2 | $1.84M | Buy |
20,440
+19,940
| +3,988% | +$1.22M | 0.03% | 753 |
|
|
2014
Q1 | $27K | Buy |
+500
| New | +$16.5K | ﹤0.01% | 4071 |
|
Group One Trading's PTX Position: Q1 2019 in Review
Group One Trading sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 18,669 shares — an estimated $8K sold.
Group One Trading first reported a position in PTX in Q2 2013 and held it in 16 quarters. The position peaked at $285K in Q2 2015. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.
- Group One Trading reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
- Group One Trading sold 18,669 Pernix Therapeutics Holdings, Inc. shares in Q1 2019, an estimated $8K.
- Group One Trading first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 16 quarters.
- Group One Trading's Pernix Therapeutics Holdings, Inc. position peaked at $285K in Q2 2015.
- 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.
Based on Group One Trading's 13F filing for Q1 2019, filed 13 May 2019.